| abstract |
The present invention relates to a compound that is a xanthine derivative, a method for producing the derivative, a pharmaceutical preparation containing the active compound, and treatment, for example, insufficient activation of the HM74A receptor contributes to the disease, and activation of the receptor It relates to the use of said compounds in the treatment of diseases that are beneficial. |